Open access · CC-BY
via OpenAlex
NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
Ana I. Rojo, Marta Pajares, Patricia Rada, Ángel Núñez, Alejo Nevado‐Holgado, Richard Killik, Fred Van Leuven, Elena M. Ribé, Simon Lovestone, Masayuki Yamamoto, Antonio Cuadrado
Redox Biology · 2017 · ▲ 216 citations
Abstract
Failure to translate successful neuroprotective preclinical data to a clinical setting in Alzheimer's disease (AD) indicates that amyloidopathy and tauopathy alone provide an incomplete view of disease. We have tested here the relevance of additional homeostatic deviations that result from loss of activity of transcription factor NRF2, a crucial regulator of multiple stress responses whose activity declines with ageing. A transcriptomic analysis demonstrated that NRF2-KO mouse brains reproduce 7 and 10 of the most dysregulated pathways of human ageing and AD brains, respectively. Then, we generated a mouse that combines amyloidopathy and tauopathy with either wild type (AT-NRF2-WT) or NRF2-deficiency (AT-NRF2-KO). AT-NRF2-KO brains presented increased markers of oxidative stress and neuroinflammation as well as higher levels of insoluble phosphorylated-TAU and Aβ*56 compared to AT-NRF2-WT mice. Young adult AT-NRF2-KO mice exhibited deficits in spatial learning and memory and reduced long term potentiation in the perforant pathway. This study demonstrates the relevance of normal homeostatic responses that decline with ageing, such as NRF2 activity, in the protection against proteotoxic, inflammatory and oxidative stress and provide a new strategy to fight AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.redox.2017.07.006
- Canonical
- link ↗
- Fetched
- 2026-07-25 MST
Cite this
APA
Rojo, A.I., Pajares, M., Rada, P., Núñez, �., Nevado‐Holgado, A., Killik, R., Leuven, F.V., Ribé, E.M., Lovestone, S., Yamamoto, M., & Cuadrado, A. (2017). NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology. <em>Redox Biology</em>. https://doi.org/10.1016/j.redox.2017.07.006
Vancouver
Rojo AI, Pajares M, Rada P, Núñez �, Nevado‐Holgado A, Killik R, et al. NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology. Redox Biology. 2017. doi:10.1016/j.redox.2017.07.006.
BibTeX
@article{ana2017NRFdef,
title = {NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology},
author = {Ana I. Rojo and Marta Pajares and Patricia Rada and Ángel Núñez and Alejo Nevado‐Holgado and Richard Killik and Fred Van Leuven and Elena M. Ribé and Simon Lovestone and Masayuki Yamamoto and Antonio Cuadrado},
journal = {Redox Biology},
year = {2017},
doi = {10.1016/j.redox.2017.07.006},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature 2014
Preprint · OA
REST and stress resistance in ageing and Alzheimer’s disease
Free Radical Biology and Medicine 2012
Preprint · OA
Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease
Free Radical Biology and Medicine 2009
Preprint · OA
Epigenetics, oxidative stress, and Alzheimer disease
Free Radical Biology and Medicine 1997
Citation only
Oxidative Stress Hypothesis in Alzheimer's Disease
Antioxidants (Basel, Switzerland) 2026
Open access · OA
From Retina to Vasculature: Oxidative Stress as a Common Mechanistic Link Between Age-Related Macular Degeneration and Cardiovascular Disease.
General Physiology and Biophysics 2021
Open access · OA